A phase II, multicenter, single-arm trial of CV301 plus atezolizumab (Atezo) in locally advanced (unresectable) or metastatic urothelial cancer (UC). Meeting Abstract (Web of Science)

Industry Collaboration

cited authors

  • Sonpavde, Guru; Maughan, Benjamin Louis; Wei, Xiao X.; McGregor, Bradley Alexander; Kilbridge, Kerry L.; Lee, Richard J.; Yu, Evan; Schweizer, Michael Thomas; Montgomery, Robert B.; Cheng, Heather H.; Hsieh, Andrew Caleb; Birhiray, Ruemu E.; Gabrail, Nashat Y.; Nemunaitis, John J.; Rezazadeh, Arash; Van Veldhuizen, Peter J.; Vogelzang, Nicholas J.; Heery, Christopher Ryan; Grivas, Petros

publication date

  • March 1, 2019

webpage

published in

category

volume

  • 37

issue

  • 7